Search for: "Energy Sa v. Center, Inc., in Re" Results 1 - 12 of 12
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Dec 2020, 7:44 am by Rebecca Tushnet
International Code Council, Inc. v. [read post]
10 Aug 2009, 6:50 am
(IP Watchdog) PLI publishes 2009 Federal Circuit Yearbook (IP Watchdog)   US Patents – Decisions CAFC: Inequitable conduct defense requires that specific facts regarding circumstances and intent to deceive must be included in pleadings: Exergen Corp v Wal-Mart Stores, Inc (Inventive Step) (IP Watchdog) (Peter Zura's 271 Patent Blog) (Patent Docs) CAFC: McNeil dodges bullet on timing of appeal filing: In re McNeil (Patent Baristas) (Peter Zura's… [read post]
9 Jan 2009, 7:00 am
(IP Think Tank) IEEE patent scorecard for 2008 is out (Innovationpartners) (Peter Zura's 271 Patent Blog) Patent databases: 2008 in review (Patent Librarian's Notebook) New kind codes for republished PCT documents (Patent Librarian’s Notebook) The model changes at PatentFreedom; Matsushita is top troll target (IAM) Patent litigation, the ITC, and hardship in the chip industry (IP finance)   Global - Copyright Public domain day 2009 (Creative Commons), (Michael Geist)… [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v Ausplow (Pty) Ltd:… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
28 Sep 2015, 6:00 am by David Kris
Today, for reasons both technological and political, there is an increasing divergence and growing conflict between U.S. and foreign laws that compel, and prohibit, production of data in response to governmental surveillance directives.[1][2]  Major U.S. telecommunications and Internet providers[3] face escalating pressure from foreign governments, asserting foreign law, to require production of data stored by the providers in the United States, in ways that violate U.S. law.[4]  At the… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]